Intro

This chapter discusses first-line endocrine-based therapies for HR-positive, HER2-negative metastatic breast cancer, using a football game metaphor to illustrate patient challenges. It explores the evolution of treatment options and recent clinical trials, focusing on improving patient outcomes and understanding their experiences.